Pancreaticobiliary cancers with deficient methylenetetrahydrofolate reductase genotypes.

[1]  E. Rimm,et al.  A prospective study of folate intake and the risk of pancreatic cancer in men and women. , 2004, American journal of epidemiology.

[2]  J. Issa,et al.  A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. , 2004, Nucleic acids research.

[3]  R. Hruban,et al.  Large-Scale Allelotype of Pancreaticobiliary Carcinoma Provides Quantitative Estimates of Genome-Wide Allelic Loss , 2004, Cancer Research.

[4]  H. Risch.  Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. , 2004, Journal of the National Cancer Institute.

[5]  J. Selhub,et al.  Combined marginal folate and riboflavin status affect homocysteine methylation in cultured immortalized lymphocytes from persons homozygous for the MTHFR C677T mutation. , 2003, The Journal of nutrition.

[6]  J. Cameron,et al.  Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. , 2003, Cancer research.

[7]  T. Glover,et al.  Common fragile sites , 2003, Cytogenetic and Genome Research.

[8]  R. Hruban,et al.  Fanconi anemia gene mutations in young-onset pancreatic cancer. , 2003, Cancer research.

[9]  T. Sanders,et al.  Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. , 2003, Gastroenterology.

[10]  R. Jaenisch,et al.  Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.

[11]  R. Hruban,et al.  Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  J. Boer,et al.  A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. , 2003, Cancer research.

[13]  Christopher F. Martin,et al.  5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  H. Dienemann,et al.  Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking. , 2002, Carcinogenesis.

[15]  G. Kauwell,et al.  Vitamin B-12 status is inversely associated with plasma homocysteine in young women with C677T and/or A1298C methylenetetrahydrofolate reductase polymorphisms. , 2002, The Journal of nutrition.

[16]  D. Girelli,et al.  A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Laird,et al.  Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic Mice. , 2002, Cancer research.

[18]  J. Cameron,et al.  The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  S. Vollset,et al.  Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. , 2001, American journal of medical genetics.

[20]  D. Albanes,et al.  Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers. , 2001, American journal of epidemiology.

[21]  H. Yamamoto,et al.  Adenocarcinomas with Widespread Microsatellite Instability Genetic and Clinical Features of Human Pancreatic Ductal Updated , 2001 .

[22]  G. M. Taylor,et al.  Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Furukawa,et al.  Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma , 2000, American Journal of Gastroenterology.

[24]  R H Hruban,et al.  Hypermethylation of multiple genes in pancreatic adenocarcinoma. , 2000, Cancer research.

[25]  G. Morgan,et al.  Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  W. Willett,et al.  A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  H. Kijima,et al.  Multiple K‐ras Mutations in Hyperplasia and Carcinoma in Cases of Human Pancreatic Carcinoma , 1999, Japanese journal of cancer research : Gann.

[28]  D. Albanes,et al.  Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. , 1999, Journal of the National Cancer Institute.

[29]  Y. Yazaki,et al.  Polymorphism of the methionine synthase gene : association with homocysteine metabolism and late-onset vascular diseases in the Japanese population. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[30]  D. Knook,et al.  Mortality risk in men is associated with a common mutation in the methylenetetrahydrofolate reductase gene (MTHFR) , 1999, European Journal of Human Genetics.

[31]  R. Hayes,et al.  Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. , 1998, Journal of the National Cancer Institute.

[32]  J. Selhub,et al.  A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Hruban,et al.  Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. , 1998, Cancer research.

[34]  G. Sozzi,et al.  When smoke gets in your genes , 1998, Nature Medicine.

[35]  T. Furukawa,et al.  Identification of two common regions of allelic loss in chromosome arm 12q in human pancreatic cancer. , 1998, Cancer research.

[36]  F. Gabreëls,et al.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? , 1998, American journal of human genetics.

[37]  B. Ames,et al.  Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Moskaluk,et al.  Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. , 1996, Cancer research.

[39]  R. Hruban,et al.  Allelotype of pancreatic adenocarcinoma using xenograft enrichment. , 1995, Cancer research.

[40]  L. Poirier,et al.  Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. , 1995, Cancer research.

[41]  R. Hruban,et al.  p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. , 1994, Cancer research.

[42]  Y. Nakamura,et al.  Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. , 1993, Cancer research.

[43]  R. Hruban,et al.  Molecular pathogenesis of pancreatic cancer. , 2006, Best practice & research. Clinical gastroenterology.

[44]  C. Yeo.  The Whipple operation: is a radical resection of benefit? , 2003, Advances in surgery.

[45]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[46]  H. Blom,et al.  Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. , 1995, American journal of human genetics.